Guidelines for the management of adult lower respiratory tract infections
Indexed incrossrefpubmed
Abstract
No risk factors for P. aeruginosa (see table 12) Nonantipseudomonal cephalosporin III+macrolide # or Nonantipseudomonal cephalosporin III+(moxifloxacin or levofloxacin) Risk factors for P. aeruginosa (see table 12) Anti-pseudomonal cephalosporin " or Acylureidopenicillin/b-lactamase inhibitor or Carbapenem + ciprofloxacin P. aeruginosa: Pseudomonas aeruginosa. # : new macrolides preferred to erythromycin
Citation impact
892
total citations
- FWCI
- 40.22
- Percentile
- 100%
- References
- 389
Citations per year
Authors
10- MWMark WoodheadCorresponding
Manchester Royal Infirmary
- FBF. Blasi
- SES. Ewig
- GHG. Huchon
- MLM. Leven
Topics & keywords
Topics
Keywords
- Guideline
- Medicine
- Intensive care medicine
- Respiratory tract infections
- Pneumonia
- Community-acquired pneumonia
- Task force
- Specialty
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.